| 10.1212/NXG.0000000000200091 |
38.235.365 |
ADA:chevret,sylvie;DA:BIARD,Lucie |
Improvement of an External Predictive Model Based on New Information Using a Synthetic Data Approach: Application to CADASIL. |
Neurol Genet |
2023 |
9 |
e200091 |
| 10.1038/s41598-023-49552-w |
38.105.268 |
3:chevret,sylvie;DA:BIARD,Lucie |
Comparison of models for stroke-free survival prediction in patients with CADASIL. |
Sci Rep |
2023 |
13 |
22443 |
| 10.1002/jmv.29319 |
38.102.899 |
ADA:chevret,sylvie |
Respiratory torque teno virus load at emergency department visit predicts intensive care unit admission of SARS-CoV-2 infected patients. |
J Med Virol |
2023 |
95 |
e29319 |
| 10.3389/fimmu.2023.1250214 |
38.077.399 |
17:resche-rigon,matthieu |
More rapid blood interferon α2 decline in fatal versus surviving COVID-19 patients. |
Front Immunol |
2023 |
14 |
1250214 |
| 10.3390/jpm13111560 |
38.003.875 |
DA:chevret,sylvie |
Bayesian Sequential Design for Identifying and Ranking Effective Patient Subgroups in Precision Medicine in the Case of Counting Outcome Data with Inflated Zeros. |
J Pers Med |
2023 |
13 |
|
| 10.1016/j.respe.2023.102189 |
37.972.522 |
3:Flicoteaux,Remi |
Development of a natural language processing model for deriving breast cancer quality indicators : A cross-sectional, multicenter study. |
Rev Epidemiol Sante Publique |
2023 |
71 |
102189 |
| 10.1111/bjh.19163 |
37.953.476 |
ADA:LAMBERT,Jerome |
Low non-relapse mortality and good haematological and renal responses after autologous haematopoietic stem cell transplantation in multiple myeloma patients with renal insufficiency at transplant: A prospective Société Francophone de Greffe de Moelle-Thérapie Cellulaire observational study. |
Br J Haematol |
2023 |
|
|
| 10.1136/bmjmed-2022-000427 |
37.920.150 |
30:resche-rigon,matthieu |
Use of covid-19 convalescent plasma to treat patients admitted to hospital for covid-19 with or without underlying immunodeficiency: open label, randomised clinical trial. |
BMJ Med |
2023 |
2 |
e000427 |
| 10.1002/cam4.6637 |
37.909.210 |
11:Flicoteaux,Remi |
Impact of the COVID-19 pandemic on clinical presentation, treatments, and outcomes of new breast cancer patients: A retrospective multicenter cohort study. |
Cancer Med |
2023 |
12 |
20918-20929 |
| 10.1186/s12874-023-02071-8 |
37.907.863 |
DA:chevret,sylvie |
How to perform prespecified subgroup analyses when using propensity score methods in the case of imbalanced subgroups. |
BMC Med Res Methodol |
2023 |
23 |
255 |
| 10.3390/cancers15204967 |
37.894.334 |
ADA:chevret,sylvie |
Real-World Diagnostic Accuracy of the On-Site Cytopathology Advance Report (OSCAR) Procedure Performed in a Multidisciplinary One-Stop Breast Clinic. |
Cancers (Basel) |
2023 |
15 |
|
| 10.1007/s00134-023-07178-6 |
37.867.165 |
3:WALTER,Anouk;ADA:chevret,sylvie |
Magnesium sulphate in patients with thrombotic thrombocytopenic purpura (MAGMAT): a randomised, double-blind, superiority trial. |
Intensive Care Med |
2023 |
49 |
1293-1304 |
| 10.1097/HEP.0000000000000615 |
37.774.387 |
6:CHAFFAUT,Cendrine |
The clinical and financial burden of nonhepatocellular carcinoma focal lesions detected during the surveillance of patients with cirrhosis. |
Hepatology |
2023 |
|
|
| 10.3899/jrheum.2023-0325 |
37.739.478 |
23:resche-rigon,matthieu |
Cluster Analysis to Explore Clinical Subphenotypes of Eosinophilic Granulomatosis With Polyangiitis. |
J Rheumatol |
2023 |
50 |
1446-1453 |
| 10.1016/j.jclinepi.2023.09.004 |
37.717.707 |
1:SERRET-LARMANDE,ARNAUD;4:LAMBERT,Jerome |
A methodological review of population-adjusted indirect comparisons reveals inconsistent reporting and suggests publication bias. |
J Clin Epidemiol |
2023 |
163 |
1-10 |
| 10.1186/s13054-023-04640-1 |
37.700.297 |
5:resche-rigon,matthieu |
Prevention of cardiac surgery-associated acute kidney injury: a systematic review and meta-analysis of non-pharmacological interventions. |
Crit Care |
2023 |
27 |
354 |
| 10.1016/j.jacc.2023.06.031 |
37.673.506 |
ADA:BIARD,Lucie |
Long-Term Outcome and Prognosis of Noninfectious Thoracic Aortitis. |
J Am Coll Cardiol |
2023 |
82 |
1053-1064 |
| 10.1001/jama.2023.15879 |
37.656.448 |
2:resche-rigon,matthieu |
PTSD Symptoms Among Family Members of Patients With ARDS Caused by COVID-19 After 12 Months. |
JAMA |
2023 |
330 |
1383-1385 |
| 10.1186/s13613-023-01168-z |
37.634.234 |
1:chevret,sylvie |
Which severe COVID-19 patients could benefit from high dose dexamethasone? A Bayesian post-hoc reanalysis of the COVIDICUS randomized clinical trial. |
Ann Intensive Care |
2023 |
13 |
75 |
| 10.1136/bmjopen-2022-071346 |
37.591.648 |
5:chevret,sylvie |
WHO O2CoV2: oxygen requirements and respiratory support in patients with COVID-19 in low-and-middle income countries-protocol for a multicountry, prospective, observational cohort study. |
BMJ Open |
2023 |
13 |
e071346 |
| 10.1002/ijc.34675 |
37.539.961 |
12:Flicoteaux,Remi |
No changes in clinical presentation, treatment strategies and survival of pancreatic cancer cases during the SARS-COV-2 outbreak: A retrospective multicenter cohort study on real-world data. |
Int J Cancer |
2023 |
153 |
1988-1996 |
| 10.1080/10543406.2023.2236216 |
37.496.233 |
2:BIARD,Lucie |
Incorporating patient-reported outcomes in dose-finding clinical trials with continuous patient enrollment. |
J Biopharm Stat |
2023 |
|
1-12 |
| 10.1007/s00431-023-05119-5 |
37.491.617 |
3:chevret,sylvie |
Association between pediatric intensive care mortality and mechanical ventilation settings during extracorporeal membrane oxygenation for pediatric acute respiratory distress syndrome. |
Eur J Pediatr |
2023 |
182 |
4487-4497 |
| 10.1016/S1470-2045(23)00282-6 |
37.429.302 |
2:chevret,sylvie |
Pembrolizumab in patients with rare and ultra-rare sarcomas (AcSé Pembrolizumab): analysis of a subgroup from a non-randomised, open-label, phase 2, basket trial. |
Lancet Oncol |
2023 |
24 |
892-902 |
| 10.1016/j.conctc.2023.101141 |
37.397.429 |
DA:chevret,sylvie |
Simulation study for evaluating an adaptive-randomisation Bayesian hybrid trial design with enrichment. |
Contemp Clin Trials Commun |
2023 |
33 |
101141 |
| 10.1111/jne.13311 |
37.345.276 |
2:resche-rigon,matthieu |
Proposal of early CT morphological criteria for response of liver metastases to systemic treatments in gastroenteropancreatic neuroendocrine tumors: Alternatives to RECIST. |
J Neuroendocrinol |
2023 |
35 |
e13311 |
| 10.1136/rmdopen-2022-002830 |
37.321.669 |
2:BIARD,Lucie |
Intravenous versus subcutaneous tocilizumab in Takayasu arteritis: multicentre retrospective study. |
RMD Open |
2023 |
9 |
|
| 10.1016/j.jhep.2023.05.025 |
37.302.582 |
9:CHAFFAUT,Cendrine;ADA:chevret,sylvie |
Hepatocyte-derived biomarkers predict liver-related events at 2 years in Child-Pugh class A alcohol-related cirrhosis. |
J Hepatol |
2023 |
79 |
910-923 |
| 10.1007/s12028-023-01758-6 |
37.286.846 |
3:resche-rigon,matthieu;8:CHAFFAUT,Cendrine |
Clinician-Reported Physical and Cognitive Impairments After Convulsive Status Epilepticus: Post Hoc Study of a Randomized Controlled Trial. |
Neurocrit Care |
2023 |
|
|
| 10.1097/HS9.0000000000000873 |
37.260.917 |
1:LAMBERT,Jerome;DA:chevret,sylvie |
Real-world Experience of Approved Chimeric Antigen Receptor T-cell Therapies Compared to Clinical Trials Data. |
Hemasphere |
2023 |
7 |
e873 |
| 10.1016/S2352-3026(23)00090-X |
37.245.522 |
20:chevret,sylvie |
CPX-351 in higher risk myelodysplastic syndrome and chronic myelomonocytic leukaemia: a multicentre, single-arm, phase 2 study. |
Lancet Haematol |
2023 |
10 |
e521-e529 |
| 10.1016/j.semarthrit.2023.152224 |
37.207.416 |
7:BIARD,Lucie |
Neutrophilic dermatosis and hidradenitis suppurativa in patients with Behçet''s disease: A neutrophilic disease in the spectrum of autoinflammatory syndromes. |
Semin Arthritis Rheum |
2023 |
61 |
152224 |
| 10.1182/bloodadvances.2023010155 |
37.205.853 |
3:LAMBERT,Jerome |
LSC17 score complements genetics and measurable residual disease in acute myeloid leukemia: an ALFA study. |
Blood Adv |
2023 |
7 |
4024-4034 |
| 10.1093/jamia/ocad048 |
37.192.819 |
39:SERRET-LARMANDE,ARNAUD |
Building a collaborative cloud platform to accelerate heart, lung, blood, and sleep research. |
J Am Med Inform Assoc |
2023 |
30 |
1293-1300 |
| 10.1002/ajh.26944 |
37.139.676 |
ADA:BIARD,Lucie |
Prognosis and long-term outcomes in type I cryoglobulinemia: A multicenter study of 168 patients. |
Am J Hematol |
2023 |
98 |
1080-1086 |
| 10.1016/S0140-6736(23)00329-X |
37.105.210 |
ADA:chevret,sylvie |
Allogeneic transplantation in advanced cutaneous T-cell lymphomas (CUTALLO): a propensity score matched controlled prospective study. |
Lancet |
2023 |
401 |
1941-1950 |
| 10.1183/13993003.02381-2021 |
37.080.573 |
8:chevret,sylvie |
Autoantibodies are associated with disease progression in idiopathic pulmonary fibrosis. |
Eur Respir J |
2023 |
61 |
|
| 10.3324/haematol.2022.281772 |
37.078.253 |
4:LAMBERT,Jerome |
Real-world study of the efficacy and safety of belantamab mafodotin (GSK2857916) in relapsed or refractory multiple myeloma based on data from the nominative ATU in France: the IFM 2020-04 study. |
Haematologica |
2023 |
108 |
2774-2782 |
| 10.1007/s00262-023-03449-9 |
37.067.554 |
2:chevret,sylvie;12:CHAFFAUT,Cendrine |
Safety and efficacy of the anti-PD1 immunotherapy with nivolumab in trichoblastic carcinomas. |
Cancer Immunol Immunother |
2023 |
72 |
2649-2657 |
| 10.1093/rheumatology/kead118 |
37.021.930 |
12:resche-rigon,matthieu |
Early-onset gout and rare deficient variants of the lactate dehydrogenase D gene. |
Rheumatology (Oxford) |
2023 |
62 |
3978-3983 |
| 10.1136/bmjopen-2022-066496 |
36.898.751 |
ADA:chevret,sylvie |
Rapid rEcognition of COrticosteRoiD resistant or sensitive Sepsis (RECORDS): study protocol for a multicentre, placebo-controlled, biomarker-guided, adaptive Bayesian design basket trial. |
BMJ Open |
2023 |
13 |
e066496 |
| 10.1016/j.dld.2023.02.011 |
36.872.200 |
3:LAMBERT,Jerome |
Prognosis and molecular characteristics of IBD-associated colorectal cancer: Experience from a French tertiary-care center. |
Dig Liver Dis |
2023 |
55 |
1280-1287 |
| 10.1093/cid/ciad070 |
36.785.526 |
2:chevret,sylvie;27:DESSEAUX,Kristell |
Antimicrobial for 7 or 14 Days for Febrile Urinary Tract Infection in Men: A Multicenter Noninferiority Double-Blind, Placebo-Controlled, Randomized Clinical Trial. |
Clin Infect Dis |
2023 |
76 |
2154-2162 |
| 10.1016/j.pediatrneurol.2023.01.013 |
36.773.407 |
3:SERRET-LARMANDE,ARNAUD |
Neurodevelopmental Outcome at Two Years for Preterm Infants With Intraventricular Hemorrhage: A Case-Control Study. |
Pediatr Neurol |
2023 |
141 |
52-57 |
| 10.1007/s00277-023-05119-3 |
36.773.040 |
2:chevret,sylvie |
Benefits of dexamethasone on early outcomes in patients with acute myeloid leukemia with hyperleukocytosis: a propensity score matched analysis. |
Ann Hematol |
2023 |
102 |
761-768 |
| 10.1016/j.stem.2023.01.006 |
36.736.290 |
58:chevret,sylvie |
Clonal hematopoiesis driven by chromosome 1q/MDM4 trisomy defines a canonical route toward leukemia in Fanconi anemia. |
Cell Stem Cell |
2023 |
30 |
153-170.e9 |
| 10.1038/s41598-023-29131-9 |
36.732.353 |
ADA:BIARD,Lucie |
Severe SARS-Cov2 pneumonia in vaccinated patients: a multicenter cohort study. |
Sci Rep |
2023 |
13 |
1902 |
| 10.1016/j.cgh.2023.01.013 |
36.731.588 |
3:LAMBERT,Jerome;13:DESSEAUX,Kristell |
Adalimumab in Biologic-naïve Patients With Crohn''s Disease After Resolution of an Intra-abdominal Abscess: A Prospective Study From the GETAID. |
Clin Gastroenterol Hepatol |
2023 |
21 |
3365-3378.e5 |
| 10.1227/neu.0000000000002301 |
36.700.711 |
3:chevret,sylvie |
Internal Ventricular Cerebrospinal Fluid Shunt for Adult Hydrocephalus: A Systematic Review and Meta-Analysis of the Infection Rate. |
Neurosurgery |
2023 |
92 |
894-904 |
| 10.1016/S2468-1253(22)00385-5 |
36.640.794 |
2:resche-rigon,matthieu |
Withdrawal of infliximab or concomitant immunosuppressant therapy in patients with Crohn''s disease on combination therapy (SPARE): a multicentre, open-label, randomised controlled trial. |
Lancet Gastroenterol Hepatol |
2023 |
8 |
215-227 |
| 10.1182/bloodadvances.2022009167 |
36.534.147 |
1:LAMBERT,Jerome;DA:chevret,sylvie |
Enriching single-arm clinical trials with external controls: possibilities and pitfalls. |
Blood Adv |
2023 |
7 |
5680-5690 |
| 10.1200/JCO.22.00437 |
36.455.187 |
5:CHAFFAUT,Cendrine;30:chevret,sylvie |
Decitabine Versus Hydroxyurea for Advanced Proliferative Chronic Myelomonocytic Leukemia: Results of a Randomized Phase III Trial Within the EMSCO Network. |
J Clin Oncol |
2023 |
41 |
1888-1897 |
| 10.1016/j.jhep.2022.11.003 |
36.427.656 |
8:CHAFFAUT,Cendrine |
Integrating genetic variants into clinical models for hepatocellular carcinoma risk stratification in cirrhosis. |
J Hepatol |
2023 |
78 |
584-595 |
| 10.1016/j.jhep.2022.11.013 |
36.423.805 |
5:CHAFFAUT,Cendrine;ADA:chevret,sylvie |
Low alcohol consumption influences outcomes in individuals with alcohol-related compensated cirrhosis in a French multicenter cohort. |
J Hepatol |
2023 |
78 |
501-512 |
| 10.1038/s41409-022-01859-4 |
36.309.588 |
ADA:chevret,sylvie |
Interstitial lung diseases after hematopoietic stem cell transplantation: New pattern of lung chronic graft-versus-host disease? |
Bone Marrow Transplant |
2023 |
58 |
87-93 |
| 10.1016/j.wneu.2022.10.073 |
36.309.337 |
2:chevret,sylvie |
Failure of Internal Cerebrospinal Fluid Shunt: A Systematic Review and Meta-Analysis of the Overall Prevalence in Adults. |
World Neurosurg |
2023 |
169 |
20-30 |
| 10.1177/0271678X221126280 |
36.254.369 |
3:BIARD,Lucie;ADA:chevret,sylvie |
Phenotypic variability in 446 CADASIL patients: Impact of NOTCH3 gene mutation location in addition to the effects of age, sex and vascular risk factors. |
J Cereb Blood Flow Metab |
2023 |
43 |
153-166 |
| 10.55563/clinexprheumatol/mm2uzu |
36.200.930 |
2:resche-rigon,matthieu |
Machine-learning derived algorithms for prediction of radiographic progression in early axial spondyloarthritis. |
Clin Exp Rheumatol |
2023 |
41 |
727-734 |
| 10.2340/jrm.v54.736 |
36.017.667 |
8:LAMBERT,Jerome |
Feasibility and Safety of Active Physiotherapy in the Intensive Care Unit for Intubated Patients with Malignancy. |
J Rehabil Med |
2023 |
55 |
jrm00299 |
| 10.1093/rheumatology/keac319 |
35.686.921 |
8:resche-rigon,matthieu |
Changes on chest HRCT in systemic sclerosis-related interstitial lung disease after autologous haematopoietic stem cell transplantation. |
Rheumatology (Oxford) |
2023 |
62 |
SI32-SI42 |
| 10.1016/j.htct.2022.05.003 |
35.673.599 |
3:chevret,sylvie |
Comparison of characteristics and laboratory tests of COVID-19 hematological patients from France and Brazil during the pre-vaccination period: identification of prognostic profiles for survival. |
Hematol Transfus Cell Ther |
2023 |
45 |
306-316 |
| 10.1016/j.jaad.2020.11.009 |
33.188.872 |
2:chevret,sylvie |
Trunk involvement and peau d''orange aspect are poor prognostic factors in eosinophilic fasciitis (Shulman disease): A multicenter retrospective study of 119 patients. |
J Am Acad Dermatol |
2023 |
88 |
160-163 |
